Top compounds associated with response to SP4


Feature Type Standardized
Nominal ANOVA
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA prima-1 CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA vincristine CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.17 3e-07
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA KPT185 CTRPv2 pan-cancer AAC 0.2 4e-07
Download CSV